PL353968A1 - Kompozycja do zapładniania in vitroKompozycja do zapładniania in vitro - Google Patents

Kompozycja do zapładniania in vitroKompozycja do zapładniania in vitro

Info

Publication number
PL353968A1
PL353968A1 PL00353968A PL35396800A PL353968A1 PL 353968 A1 PL353968 A1 PL 353968A1 PL 00353968 A PL00353968 A PL 00353968A PL 35396800 A PL35396800 A PL 35396800A PL 353968 A1 PL353968 A1 PL 353968A1
Authority
PL
Poland
Prior art keywords
ivf
composition
phosperglycid
protein
prepared
Prior art date
Application number
PL00353968A
Other languages
English (en)
Other versions
PL202224B1 (pl
Inventor
Tina MeinertzAndersen Tina Meinertz Andersen
Original Assignee
Novo Nordisk A/Snovo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/Snovo Nordisk A/S filed Critical Novo Nordisk A/Snovo Nordisk A/S
Publication of PL353968A1 publication Critical patent/PL353968A1/pl
Publication of PL202224B1 publication Critical patent/PL202224B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL353968A 1999-09-16 2000-09-11 Stała kompozycja farmaceutyczna zawierająca związek HSA PL202224B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901308 1999-09-16
PCT/DK2000/000500 WO2001019354A2 (en) 1999-09-16 2000-09-11 Composition for ivf

Publications (2)

Publication Number Publication Date
PL353968A1 true PL353968A1 (pl) 2003-12-15
PL202224B1 PL202224B1 (pl) 2009-06-30

Family

ID=8103409

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353968A PL202224B1 (pl) 1999-09-16 2000-09-11 Stała kompozycja farmaceutyczna zawierająca związek HSA

Country Status (21)

Country Link
US (1) US6844313B1 (pl)
EP (1) EP1216059B1 (pl)
JP (1) JP2003509365A (pl)
KR (1) KR100757909B1 (pl)
CN (1) CN1222319C (pl)
AT (1) ATE306942T1 (pl)
AU (1) AU781994B2 (pl)
BR (1) BR0014058A (pl)
CA (1) CA2382908A1 (pl)
CZ (1) CZ2002591A3 (pl)
DE (1) DE60023324T2 (pl)
ES (1) ES2252048T3 (pl)
HU (1) HUP0202630A3 (pl)
IL (1) IL148234A0 (pl)
MX (1) MXPA02002439A (pl)
NO (1) NO323694B1 (pl)
PL (1) PL202224B1 (pl)
RU (1) RU2263516C2 (pl)
UA (1) UA78183C2 (pl)
WO (1) WO2001019354A2 (pl)
ZA (1) ZA200201383B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
JP2003509365A (ja) 1999-09-16 2003-03-11 ノボ ノルディスク アクティーゼルスカブ Ivf用の組成物
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175074A (en) 1976-08-23 1979-11-20 Deshmukh Arvind D Serum-soluble cholesterol compounds and method for their preparation
US4751219A (en) 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
AU4312489A (en) * 1988-09-23 1990-04-18 Cetus Corporation Lipid microemulsions for culture media
DE4221880A1 (de) 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
JPH08503950A (ja) * 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
EP0813595A1 (en) * 1995-03-06 1997-12-29 Novo Nordisk A/S Stimulation of meiosis
ATE254628T1 (de) 1995-06-23 2003-12-15 Novo Nordisk As Meiose regulierende verbindungen.
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
EP0946584B1 (en) * 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
IL132799A0 (en) 1997-06-04 2001-03-19 Akzo Nobel Nv 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
KR20010043828A (ko) 1998-05-26 2001-05-25 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 cAMP-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
JP2003509365A (ja) 1999-09-16 2003-03-11 ノボ ノルディスク アクティーゼルスカブ Ivf用の組成物

Also Published As

Publication number Publication date
RU2263516C2 (ru) 2005-11-10
KR100757909B1 (ko) 2007-09-11
WO2001019354A2 (en) 2001-03-22
ZA200201383B (en) 2002-11-27
KR20020032593A (ko) 2002-05-03
NO20021309D0 (no) 2002-03-15
IL148234A0 (en) 2002-09-12
EP1216059B1 (en) 2005-10-19
JP2003509365A (ja) 2003-03-11
HUP0202630A2 (hu) 2002-12-28
PL202224B1 (pl) 2009-06-30
MXPA02002439A (es) 2002-07-30
EP1216059A2 (en) 2002-06-26
ES2252048T3 (es) 2006-05-16
CN1373675A (zh) 2002-10-09
AU781994B2 (en) 2005-06-23
BR0014058A (pt) 2004-03-30
DE60023324D1 (de) 2005-11-24
CA2382908A1 (en) 2001-03-22
NO323694B1 (no) 2007-06-25
AU6985000A (en) 2001-04-17
UA78183C2 (en) 2007-03-15
CZ2002591A3 (cs) 2002-08-14
NO20021309L (no) 2002-03-15
WO2001019354A3 (en) 2001-06-14
HUP0202630A3 (en) 2004-06-28
US6844313B1 (en) 2005-01-18
ATE306942T1 (de) 2005-11-15
CN1222319C (zh) 2005-10-12
DE60023324T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
ID28965A (id) Azabisikloalkana sebagai modulator ccr5
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
ID29031A (id) Piperidin sebagai modulator ccr5
AU1482501A (en) Animal carrier
IL139862A0 (en) Thiazolidine or pyrrolidine derivatives as dipeptidyl peptidase iv effectors and pharmaceutical compositions containing the same
SE9704546D0 (sv) Novel compounds
PL348115A1 (en) Novel membrane or matrix for controlling drug permeation
ZA200106104B (en) Pharmaceutical composition containing proton pump inhibitors.
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
TW200640505A (en) Device comprising VGF polypeptides
AU9534398A (en) Novel pharmaceutical composition
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA200006463B (en) Composition for keeping away vermin.
AP2001002220A0 (en) Calcilytic compounds.
GB9907571D0 (en) Compounds
MY124078A (en) Eletriptan hydrobromide monohydrate
AU7978000A (en) Indium-enhanced bipolar transistor
IL148234A0 (en) Composition for ivf
AU6306000A (en) Linear accelerator
CA2268796A1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
EP1278520A4 (en) DIARYL PIPERIDYL-PYRROLE DERIVATIVES AS AN ANTIPROTOZENE AGENT
AU2002331847A1 (en) Composition for stabilizing biological materials
AU7017300A (en) Biological device, especially for cell culture
AU8241498A (en) Electrochromic light-attenuation or -filtration device
AU3416995A (en) Endothelin receptor antagonists

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090911